Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Contact | Phase 3 | CN | 15 Mar 2019 | |
Eczema | Phase 3 | CN | 15 Mar 2019 | |
Lichen Planus | Phase 3 | CN | 15 Mar 2019 | |
Lupus Erythematosus, Discoid | Phase 3 | CN | 15 Mar 2019 | |
Neurodermatitis | Phase 3 | CN | 15 Mar 2019 | |
Psoriasis | Phase 3 | CN | 15 Mar 2019 | |
Sunburn | Phase 3 | CN | 15 Mar 2019 | |
Varicose Veins | Phase 3 | CN | 15 Mar 2019 | |
Dermatitis, Atopic | Phase 1 | CN | 07 Jan 2020 | |
Dermatitis, Occupational | Phase 1 | CN | 07 Jan 2020 |